Abstract
The pharmacokinetic profile of oral zidovudine entrapped in a 50:50 polyactide-coglycolide matrix (nanospheres) was compared to those of standard oral and parenteral zidovudine formulations in rabbits. The bioavailability of zidovudine nanospheres at 50 mg/kg of body weight was 76%, and this dose achieved prolonged exposure to zidovudine compared to standard formulations without an increase in the drug's peak concentration.
Original language | English (US) |
---|---|
Pages (from-to) | 972-974 |
Number of pages | 3 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 43 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1999 |
Externally published | Yes |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases